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Maternal malnutrition continues to be a significant 
contributor to adverse reproductive outcomes in 
developing countries, despite longstanding efforts to 
fortify foods or distribute medicinal supplements to 
1pregnant women . In the developing world, the 
majority of women who enter pregnancy are 
anaemic. Anaemia in these populations is often 
exacerbated by a high prevalence of infections with 
2,3,4 5intestinal parasites , malaria and HIV  and the 
6,7,8occurrence of haemoglobinopathies .
Iron deficiency anaemia is common in pregnancy, 
and may be accompanied by other micronutrient 
deficiencies, because both can result from high rates 
of infection, diarrhoea, anorexia, poor dietary 
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ABSTRACT
CONTEXT: Anaemia continues to be a leading contributor to adverse reproductive outcomes in the developing 
countries. Although, the commonest cause of anaemia in pregnancy is iron deficiency, the enormous contributions of 
other micronutrients have been underestimated. As a result, the need to identify relevant micronutrients, which 
complement iron, in haematopoiesis cannot be over emphasized.
OBJECTIVES: To determine the effect of some micronutrients (Cyanocobalamin, {B12}2500µg, folic acid 0.7mg,  
niacin12mg and ascorbic acid 150mg; Eldervit-12) on some haematological parameters of anaemic pregnant women.   
SUBJECTS AND METHODS: ONE hundred and sixty two (162) anaemic pregnant women aged between 18-38 
years were recruited into the study, and randomly divided into two groups.  The test group was given two weekly 
Eldervit-12 injections intramuscularly, and the control group was given placebo (water for injection). Packed cell 
volume (PCV), reticulocyte count, white cell count and platelet count were estimated before and at the end of the 
injections using established methods. Student t-test was used to determine test for significance between the groups.
RESULTS: The PCV increased significantly from 25.9± 2.2% and 26.2± 2.2% to 37.3% ± 2.6% and 32.4%± 1.9% 
respectively for test and control (P< 0.001). The PCV increase was however, significantly higher in the test when 
compared with the control (P< 0.001). The reticulocyte count also increased significantly from 2.2% ± 0.7% and 
2.3%± 0.7% to 4.7%V 0.8 % and 2.9% ± 0.7 % respectively for test and control (P<0.001). But the test showed a more 
significant increase than the control (P< 0.001). There were no significant differences in the WBC and platelet counts 
(P> 0.05).    
CONCLUSION: Additional micronutrients play a vital role in the management of anaemia in pregnancy. Efforts 
should be made to qualify and quantify these in other to obtain the actual daily requirements. 
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9quality and nutrient bioavailability . The 
coexistence of these micronutrient deficiencies and 
iron deficiency may increase the risk of anaemia and 
limit the haematological response to iron 
9supplementation . According to Beaton and 
35
Trop J Obstet Gynaecol, Vol 27 (2), August 2010
McCabe, 1999, something other than iron may be 
operating to limit haemoglobin response and 
10anaemia control .
The deleterious effects of anaemia in pregnancy on 
both mother and child will continue to constitute a 
11,12
burden in our contemporary obstetric practice . 
The incidence is still remarkably high, despite the 
lower level of normal we have adopted in our own 
13,14
definition .There is no doubt that iron deficiency is 
the commonest cause of anaemia in pregnancy in our 
13
environment.  However, the enormous contribution 
of other micronutrients in erythropoiesis cannot be 
over looked.  Studies have shown that despite 
routine iron supplementation, high incidence of 
15,16anaemia still exist.
This may be as a result of poor compliance, 
inadequate duration of supplementation of other 
micronutrients or inadequate treatment of other 
related factors, low intake of enhancers of iron 
absorption and high intake of inhibitors of iron 
9absorption such as phytates and oxalates . Several 
studies have identified multiple micronutrient 
deficiencies (Vitamins, B12, B2, B6, folate, zinc, 
ascorbic acid, vitamin E) in association with iron 
17,18,19 
deficiency. Major physiological changes in 
pregnancy such as plasma volume expansion which 
alters blood chemistry and increases maternal to 
foetal transfer of nutrients, and increased utilization 
of some of these micronutrients as defense 
mechanisms against pregnancy induced oxidative 
20, 21stress may be the contributing factors.  More 
recently an analysis of multiple vitamin status of 
anaemic and non anaemic pregnant women showed 
a positive correlation between abnormal 
haematological results and prevalence of vitamin 
deficiencies.  The subjects with iron deficiency 
anaemia had much higher rates of vitamin C, folate 
and vitamin B12 deficiencies than the nonanaemic 
22subjects.   
In addition to the burden of these nutritional 
anaemias, malaria parasitaemia is particularly 
23,24,25
prevalent in our environment,.  a n d  
contributes significantly in the aetiology of anaemia 
2 6 , 2 7 , , 2 8 ,
in pregnancy  by causing chronic 
29,30.
haemolysis .Treatment with iron alone in this 
circumstance without knowing the serum level may 
cause over load which could boost the production of 
free radicals resulting in adverse cellular damage; 
31including the red blood cell. .
  Few studies have examined the added benefit of 
multiple micronutrients over iron alone in reducing 
24anaemia and iron deficiency during pregnancy . We 
therefore, decided to assess the impact of some of 
these micronutrients on some haematological profile 
of anaemic pregnant women who are already on the 
conventional treatment for anaemia in pregnancy.  
PATIENTS AND METHODS 
Study Design and setting
This is a single blind, placebo controlled, 
randomized clinical trial. A total of 162 (one hundred 
and sixty two) pregnant anaemic patients(PCV 
<30%) seen, at University of Nigeria Teaching 
Hospital (UNTH) Enugu, Chukwuasokam maternity 
Hospital Emene and Kenechukwu Specialist 
Hospital Abakpa were recruited for the study. They 
were aged between 18-38 years and at 18 to 28 weeks 
gestational age. They were of the same social class 
and had a minimum of secondary school education. 
nd thThe study lasted from 22  March 2004 to 4  October 
2004 (7 Months). 
Subjects with febrile conditions, multiple 
pregnancy, preeclampsia, diabetes mellitus, chronic 
renal disease, sickle Cell anaemia, HIV infections 
and subjects who dislike injections were excluded 
from the study. Those whose oral haematinic drug 
compliance could not be guaranteed were also 
excluded. 
After obtaining ethical approval and informed 
consent, we consecutively recruited 300 patients that 
met the above criteria and estimated their PCV. 
Those with PCV of less than 30 % (162) were 
selected and randomly divided into two groups using 
simple random sampling. One hundred and twenty 
two (122) subjects completed the test (75% 
compliance), sixty-five (65) test and fifty seven (57) 
control.
The following haematological indices were 
measured at the beginning of the test and between 
36-38 weeks gestation.  Packed cell volume (PCV), 
reticulocyte count, white cell count and platelet 
c o u n t .  P C V w a s  e s t i m a t e d  u s i n g  t h e  
microhaematocrit method, reticulocyte count by the 
supravital staining method, WBC total, by the Turk's 
solution method, and platelet count by the 
ammonium oxalate method. The study group was 
given intramuscular Eldervit- 12 injections (A and B 
containing Cyanocobalamin, B12, 2500µg, folic  
acid 0.7mg, niacin12mg and ascorbic acid 150mg) 
once every 2 weeks, while the control group was 
given intramuscular water for injection.  Both 
groups were on conventional treatment with iron.  
They were also encouraged to continue their normal 
routine antenatal drugs, (folic acid, multivitamin, 
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vitamin C, and calcium lactate) at normal dose. They 
all had anti malaria treatment (intermittent 
p r e v e n t i v e  t r e a t m e n t )  w i t h  
sulphadoxine/pyremethamine combination in the 
 second and third trimester. 
Values were recorded as mean ± standard deviation. 
Analysis of data was done using spss version 11. 
Comparison of the mean was by the student paired t-
test at 95 %confidence intervals. Values ≤ 0.05 were 
considered as significant.
RESULTS 
The mean age of the subjects was 30 ± 4.2 years 
while the mean gestational age at recruitment was 22 
±3.1 weeks. The mean parity was 3 ±1.4.
Table I shows that the mean PCV was 25.9± 2.2% for 
test and 26.2± 2.2% for control. This significantly 
increased to 37.3 ± 2.6% and 32.4±1.9% 
respectively (P<0.001). However, comparison of the 
final value, showed the test group 37.3 ± 2.6% was 
significantly higher than the control 32.4± 1.9%(P< 
0.001). In table 2, the mean reticulocyte count was 
2.2± 0.7% and 2.3 ± 0.7% respectively for test and 
control. The test group significantly increased to 4.7 
± 0.8 %,(p<0.001),and the control also showed a 
significant increase to 2.9 ± 0.7 %( P< 
0.001).However,there was a significant difference in 
the final treatment values for test 4.7 ± 0.8 % and 
control 2.9± 0.7 %(p<0.001). Table 3 shows the total 
white cell count for test and control before treatment 
9 9
of 5.4±1.8x10 /L and 5.3±1.8x10 /L respectively, 
9
and after treatment of 5.5±1.8 x10 /L and 5.7±1.9 
9
x10 /L respectively. Table 4 presents the platelet 
count for test and control before treatment of 
3 3
174±79x10 / µL and 176±79x10 / µL respectively 
3
and after treatment of 172±79x10 / µL and 
3
179±80x10 / µL respectively. The results of white 
cell and platelet counts showed no significant 
difference (p>0.05).     
Only 42 subjects from test group and 35 from the 
control delivered at the various hospitals. There were 
no significant differences in the Apgar scores 
7.3±1.2 for test and 7.2±1.2 for control at one 
minute, and 9.4±1.5 for test and 9.3±1.5 for control 
at 5 minutes(p>0.05). The mean birth weights were 
3.84±0.5 Kg for test and 3.82±0.5kg for control 
respectively and there were no differences noted 
(p>0.05).There were also no adverse drug reactions 
recorded. There were no intrauterine foetal deaths, 
preterm deliveries, congenital abnormalities, or need 
for new born special care admission in both groups.
DISCUSSION 
In this study, the PCV and reticulocyte count 
increased significantly in both the test and control 
subjects. The mean values of PCV and reticulocytes 
after treatment were however significantly higher in 
the tests when compared with controls. In a similar 
study conducted in Nigeria to determine the effect of 
the same preparation in the prevention of anaemia in 
pregnancy, the superiority of this additional 
35micronutrient was clearly demonstrated. There 
were no differences in the white cell and platelet 
count. A significantly higher reticulocyte count 
indicates a higher bone marrow activity in the 
Eldervit group. 
Iron deficiency remains the commonest single 
32
deficiency leading to anaemia .  As a result, in the 
past pregnant women with anaemia were mainly 
treated for iron deficiency in most centers using oral 
iron, or parenteral iron as the case may be.  It was not 
even found necessary to increase the dose of the 
13other hematinics.  We have thus been able to show 
that additional micronutrients provide better 
haematological response than when iron is used 
alone. Studies have shown that iron deficiency 
anaemia does not occur in isolation but with 
17,18,19. associated multivitamin deficiencies.  An 
isolated study in South East Nigeria found 
megaloblastic anaemia to be more common than iron 
33.deficiency anaemia in pregnant women  However, 
in that study, serum iron, serum ferritin, total iron 
binding capacity, folic acid and B levels were not 12 
determined.  Studies have also shown that additional 
micronutrients had better effect on some 
haematological indices than when the conventional 
34,35.
iron and folic acid was used alone .
The contribution of other micronutrients in the 
aetiology of anaemia in pregnancy has been under 
estimated. Recent studies have continued to 
highlight the significant role of other micronutrients 
36,37,38,39in health and disease.   Iron deficiency does not 
occur in isolation, thus all efforts aimed at treatment 
should include the replacement of other 
micronutrients.  Even if they do not directly 
stimulate erythropoiesis, they complement the 
action of iron, may act as antioxidants to prevent free 
radicals damage and may act as coenzymes in other 
cellular metabolisms necessary for healthy mother 
and child. This drug contains an antioxidant 
micronutrient (ascorbic acid) whose level has been 
shown to reduce significantly during normal 
40
pregnancy . It may have assisted in preventing free 
radical damage to red blood cell membrane of the 
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test subjects. However the dose of ascorbic acid in 
this compound preparation is too small to mop up all 
the free radicals generated by pregnancy induced 
oxidative stress.
All the patients were of same social class and were 
expected to be on average diet. Parental route of 
administration ensured strict compliance for the test 
subjects. Prophylactic antimalaria was given to 
eliminate the significant contribution to anaemia in 
pregnancy by plasmodium falciparum induced 
haemolysis.  However there was no guarantee that 
all had good compliance with the oral haematinics. If 
we had the facilities and resources, it would have 
been more appropriate to determine the serum levels 
of the major micronutrients involved in the aetiology 
of anaemia in pregnancy. This will enable us 
determine the actual daily dose required during 
pregnancy. We had no facilities for electronic 
counting for white cell and platelet count and that 
could have resulted in our inability to reach any 
conclusion on these parameters. Although the 
highest degree of professionalism in this study, a 
double blind placebo controlled randomized clinical 
trial would have been more appropriate to 
completely eliminate micro elements of bias. There 
were no adverse drug reactions as the drugs are water 
soluble vitamins and toxicity is rare.  
Malaria, as a significant contributor to anaemia in 
pregnancy in our environment does not lead to iron 
depletion. It is thus important, if facilities are 
available to determine the serum levels of iron in 
these patients in other to prevent iron over load. 
Alternatively, studies should be conducted using 
reduced amounts of iron and increased amount of 
other micronutrients. Further studies should also 
include the determination of actual levels of these 
micronutrients in pregnancy so as to quantify the 
daily amount needed for replacement therapy. 
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TABLE 1: MEAN PCV VALUES . 
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